Pharma and Biotech
£1m subscription to accelerate AI drug disc... | 11-Jul-2025 | 07:00 | RNS |
Holding(s) in Company | 08-Jul-2025 | 07:00 | RNS |
AGM Statement | 27-Jun-2025 | 14:38 | RNS |
Holding(s) in Company | 27-Jun-2025 | 08:54 | RNS |
Allowance of U.S. patent covering AI-supported CNS | 23-Jun-2025 | 07:00 | RNS |
Initiation of AI supported CNS drug discovery | 11-Jun-2025 | 07:30 | RNS |
Synthesis of development candidate for SVN-SDN-014 | 05-Jun-2025 | 07:00 | RNS |
Notice of Annual General Meeting | 03-Jun-2025 | 16:30 | RNS |
Appointment of Prof. David Nutt as CSO | 03-Jun-2025 | 07:00 | RNS |
Holding(s) in Company | 02-Jun-2025 | 11:58 | RNS |
Total Voting Rights | 30-May-2025 | 17:00 | RNS |
Holding(s) in Company | 29-May-2025 | 15:11 | RNS |
Holding(s) in Company | 29-May-2025 | 12:02 | RNS |
Holding(s) in Company | 29-May-2025 | 10:30 | RNS |
Holding(s) in Company | 28-May-2025 | 07:30 | RNS |
Currency | UK Pounds |
Share Price | 0.33p |
Change Today | 0.040p |
% Change | 13.79 % |
52 Week High | 0.35 |
52 Week Low | 0.12 |
Volume | 149,063,211 |
Shares Issued | 5,909m |
Market Cap | £19.50m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:40 | 77,938 @ 0.33p |
16:40 | 77,938 @ 0.33p |
16:29 | 1,883,954 @ 0.33p |
16:28 | 3,035,465 @ 0.33p |
16:18 | 90,000 @ 0.33p |
CEO | Anthony Tennyson |
Chair | Dennis Purcell |
Finance Director | Ryan Neats |
You are here: research